(redirected from Adderall XR)
Also found in: Medical.
Related to Adderall XR: Concerta


A trademark for a drug containing a combination of amphetamine and dextroamphetamine salts.
References in periodicals archive ?
Adzenys ER oral suspension utilizes the same proprietary modified-release drug delivery technology as Adzenys XR-ODT and is bioequivalent to Adderall XR.
Shire is a Jersey-registered, biopharmaceutical company, originating in the United Kingdom with an operational base in the United States, and brands and products that include Vyvanse, Lialda and Adderall XR.
Cooley advised Prasco Laboratories on its agreements with Teva Pharmaceutical Industries and Shire to acquire the rights to distribute authorized generic versions of Adderall XR Extended Release Capsules, and represented Prasco before the Federal Trade Commission in obtaining approval for the acquisition.
Medications in this category include Adderall XR, Concerta, Ritalin LA and Vyvanse.
Adzenys XR-ODT is bioequivalent to Adderall XR, one of the most commonly prescribed medications for the treatment of ADHD.
The newly approved agent is bioequivalent to Adderall XR, and patients taking Adderall can be switched to the new drug.
2) The newly approved agent is bioequivalent to Adderall XR (the capsule form of extended-release mixed amphetamine salts), and patients taking Adderall XR can be switched to the new drug.
Shire, the pharmaceuticals company dropped 11% after the US Food and Drug Administration approved a rival's application to make a generic version of its attention deficit and hyperactivity disorder drug, Adderall XR.
Pharmaceuticals company Shire was the biggest top flight faller, down 11% or 223p to 1743p, after US regulators approved generic copies of its hyperactivity drug Adderall XR.
Biopharmaceutical company Shire headed up the FTSE 100 Index's biggest fallers board yesterday after the US Federal Drug Administration (FDA) cleared a low price generic version of its hyperactivity drug Adderall XR by rival Actavis.
The FDA warned the makers of Adderall XR, Methylin, and Focalin XR for implying these drugs can reduce the negative consequences that are seen with ADHD.
Warning letters were sent to the makers of Adderall XR, Concerta, Focalin XR, Methylin, and Strattera, FDA spokesperson Sandra Walsh said in an interview.